Advertisements



Gemphire Therapeutics announces termination of Phase 2a trial of gemcabene

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Gemphire Therapeutics (GEMP) Gemcabene Indigo Phase 2 Trial Results - Slideshow

Gemphire Therapeutics (GEMP) Gemcabene Indigo Phase 2 Trial Results - Slideshow.....»»

Category: topSource: seekingalphaJun 29th, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Cara Therapeutics announces dosing of patients in Phase 2 trial of Oral Korsuva

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2018

Aclaris Therapeutics announces data for ATI-502 Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Sage Therapeutics announces pivotal Phase 3 trial for SAGE-217

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Tenax Therapeutics announces study design for Phase 2 Trial of levosimendan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2018

Menlo Therapeutics announces results from Phase 2 trial of Serlopitant

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 8th, 2018

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in na├»ve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Category: earningsSource: benzingaAug 17th, 2018

Ovid Therapeutics announces Phase 2 STARS topline data accepted for presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Results

Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial R.....»»

Category: earningsSource: benzingaAug 14th, 2018

Realm Therapeutics reports preliminary data from Phase 2 trial of PR022

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2018

Gemphire Therapeutics stock plunges after trial halted due to "unanticipated problems"

Shares of Gemphire Therapeutics Inc. plunged 17% toward a record low F.....»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics stock tumbles 17% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics" stock extends slide, plummets 39% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Iterum Therapeutics initiates SURE 1 Phase 3 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update Phase 2b Results for Topical Ocular Reproxalap in Dry Eye Disease Expected in Late Third Quarter or Early Fourth Quarter 2018 Cli.....»»

Category: earningsSource: benzingaAug 9th, 2018

Eidos Therapeutics plans to complete Phase 2 ATTR-CM trial by 2018-end

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy

Audentes Therapeutics Reports Seco.....»»

Category: earningsSource: benzingaAug 7th, 2018

Ovid Therapeutics shares fall 28% as investors question new drug data (OVID)

Markets Insider New York-based biotech company Ovid Therapeutics announced on Monday positive phase 2 trial results for its treatment for a rare disease called Angelman Syndrom.....»»

Category: topSource: businessinsiderAug 6th, 2018

Ovid Therapeutics says Phase 2 STARS Trial of OV101 achieved primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2018